Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Taysha Gene Therapies, Inc. (TSHA)

NASDAQ

$5.04

$-0.04

(-0.73%)

Pre-Market

Taysha Gene Therapies, Inc. (TSHA) Live Price Chart

Last updated: ⁦2026-09-16 09:04:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Taysha Gene Therapies, Inc. (TSHA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $5.04, with a market capitalisation of $1.63B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.71 to $7.30. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.63B
Open	$5.08
Day's High	$33.35
Day's Low	$0.50
Previous Close	$5.06
Volume	--
Average Volume	3.15M
P/E Ratio	--
52-Week High	$7.30
52-Week Low	$2.71
Dividend Yield	--
Earnings Date	--

Taysha Gene Therapies, Inc. (TSHA) Pre-Market Stock Price

Taysha Gene Therapies, Inc. (TSHA) is trading at $5.04 in pre-market trading as of 2026-09-16 08:01:00, down 0.38% ($0.02) from the previous close of $5.06

Pre-market trading shows how investors are pricing TSHA before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Taysha Gene Therapies, Inc. (TSHA) 7-Day Stock Price Change

Over the past seven days, Taysha Gene Therapies, Inc. (TSHA) moved from $5.60 to $5.04, representing a decline of 9.98% ($0.56).

The stock traded between $4.90 and $5.61 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 3.17 million shares, up versus the previous seven-day period, indicating higher trading activity.

TSHA 52-Week Price Position

Position in Range: 50.8%

52W Low$2.71

52W High$7.30

TSHA is currently trading at $5.04, placing it 50.8% of the way from its 52-week low of $2.71 to its 52-week high of $7.30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Taysha Gene Therapies, Inc. (TSHA)?

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Taysha Gene Therapies, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	99
Exchange	NASDAQ
Company Website	https://www.tayshagtx.com

How to Buy Taysha Gene Therapies, Inc. (TSHA) Stock on MEXC

Eligible investors can buy real shares of Taysha Gene Therapies, Inc. (TSHA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TSHA and Place Your Order

Open the RealStocks trading page and search for TSHA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Taysha Gene Therapies, Inc. (TSHA) stock price today?

Taysha Gene Therapies, Inc. (TSHA) is currently trading at $ 5.04, down 0.38% ($0.02) from the previous close of $ 5.06. Intraday prices update in real time during regular trading hours.

2.Is TSHA stock going up or down today?

As of 2026-09-16 08:01:00, TSHA is trading at $ 5.04, down 0.38% ($0.02) from its previous close of $ 5.06. The stock has traded between $ 0.50 and $ 33.35 during today’s regular session. Past price movements do not guarantee future results.

3.What is TSHA pre-market price?

As of 2026-09-16 08:01:00, TSHA is trading at $ 5.04 in pre-market trading, down 0.38% ($0.02) from the previous close of $ 5.06. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TSHA after-hours price?

As of 2026-09-16 08:01:00, TSHA is trading at $ 5.09 in after-hours trading, up 0.51% ($0.03) from the regular-session close of $ 5.06. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TSHA stock trading now?

TSHA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TSHA sit relative to its 52-week high and low?

Over the past 52 weeks, TSHA has traded between a low of $ 2.71 and a high of $ 7.30. At $ 5.04, the stock is positioned 50.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Taysha Gene Therapies, Inc. in?

Taysha Gene Therapies, Inc. (TSHA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Taysha Gene Therapies, Inc.'s market capitalisation and where is it listed?

Taysha Gene Therapies, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 1.63B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TSHA valued in terms of P/E ratio and EPS?

TSHA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.46. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Taysha Gene Therapies, Inc. pay a dividend?

Taysha Gene Therapies, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.